Houman Ashrafian

Houman Ashrafian is the current Director at TRex Bio. Houman has also previously worked as the Director at Mestag Therapeutics, Alchemab Therapeutics Ltd, Dementia Discovery Fund, Karus Therapeutics Limited, and TRex Bio. Houman has also worked as a Principal at Catamaran Bio, Zarodex Thereapeutics, and Enara Bio. Prior to their current positions, they worked as an Associate at SV Health Investors.

Houman Ashrafian's educational career consists of completing a Doctor of Philosophy (Ph.D.) in Cardiovascular|Medicine from the University of Oxford, a BM BCh in Medicine from the University of Oxford, and a BA (Hons) in Medicine from the University of Cambridge.